Indian drugmaker Glenmark Pharmaceuticals has announced that Alessandro Riva will join its new innovation company as chief executive. The appointment is effective April 2, 2019. 7 March 2019
Dutch biopharma Kiadis Pharma today announced senior management appointments to further strengthen the company as it transitions into commercial stage. 6 March 2019
USA-based Corbus Pharmaceutical has announced the appointment of Craig Millian to the company as its first chief commercial officer ahead of the potential US Food and Drug Administration approval and commercial launch of its lead drug candidate lenabasum in 2021. 5 March 2019
US-based Sunovion Pharmaceuticals, a subsidiary of Japan’s Sumitomo Dainippon Pharma, has appointed Antony Loebel as president and chief executive. 5 March 2019
UK-based biotech firm Emergex Vaccines today announces the appointment of Athanasios Papadopoulos as chief medical officer, effective March 1, 2019. 27 February 2019
A woman who has been involved in biosimilars since work on their development first began two decades ago, has been named director general of the International Generic and Biosimilar medicines Association (IGBA). 21 February 2019
The UK’s BioIndustry Association (BIA) chairwoman Dr Jane Osbourn has announced this week that she is to leave AstraZeneca after 25 years with Cambridge Antibody Technology and MedImmune, where she is vice president R&D and site leader, the trade group announced yesterday. 19 February 2019
Mundipharma has appointed Patrice Grand as European director of corporate communications, reporting to Alberto Martinez, president and chief executive in Europe. 18 February 2019
Spanish family-owned drugmaker Esteve has appointed Jordi Muntañola as the new chief commercial officer for Europe, taking on the leadership of all the pharmaceutical activities in Spain and Europe. 15 February 2019
Privately-held French drugmaker Pierre Fabre Group has appointed Maarten Kraan to the position of director of research and development for Pierre Fabre Pharmaceuticals (PFM), reporting to Frédéric Duchesne, chief executive of the Pharmaceuticals Division, and will sit on the branch’s executive committee. 8 February 2019
Appaloosa, the US hedge fund managed by billionaire David Tepper, has called for major and immediate change at Allergan, the Ireland-based drugmaker that is best known for its Botox (onabotulinumtoxinA) product. 6 February 2019
Dutch biopharma Kiadis Pharma has announced the appointment of Robert Friesen as chief scientific officer (CSO) effective February 1, 2019. 5 February 2019
Sir Philip Hampton, who since 2015 has been the non-executive chairman of GlaxoSmithKline, will step down from the role with the UK drugmaker. 21 January 2019
Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the appointments of Andre Hoekema as chairman of the board and Cora Griffin as head of business development. 2 October 2024
NK:IO, a London startup developing a cell therapy for treating solid tumors, has announced the appointment of a permant chief executive and the finalization of a seed funding round. 2 October 2024
Halda Therapeutics, a US biotech company advancing cancer treatments, announced the appointment of Christian Schade as president and chief executive. 1 October 2024
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has announced the appointment of Jane Rhodes as chief executive officer. 1 October 2024
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
USA-based engineered regulatory T cells (Tregs) company GentiBio today announced the appointment of Dr Mark Bach as chief medical officer. 30 September 2024
Acadia Pharmaceuticals has appointed Catherine Owen Adams to succeed Steve Davis as chief executive (CEO) and a member of its board of directors. 28 September 2024
Recently-created by US biotech incubator Flagship Pioneering, Abiologics has announced the appointment of Maria-Chiara Magnone as its chief scientific officer. 26 September 2024
German privately-held biotech ARTCLINE Bio-Therapies today announced the appointment of Dirk Hessel as additional managing director of the company. 23 September 2024
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024